Phase I safety, tolerability, and pharmacokinetic trial of CVT 301 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 30 Oct 2012
At a glance
- Drugs Levodopa (Primary) ; Levodopa (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics
- 30 Oct 2012 New trial record
- 15 Oct 2012 Results will be presented at the Sixth Annual Parkinson's Disease Therapeutics Conference according to a Civitas Therapeutics media release. Brief results were also summarised in the media release.